Increased cardiovascular risk and premature atherosclerosis in rheumatoid arthritis;Augmentation du risque cardiovasculaire et accélération de l'athérosclérose au cours de la polyarthrite rhumatoïde

Annales de Cardiologie et d'Angeiologie

Volumn 61, Issue 4, 2012, Pages 267-273

  Akrout, R ^a   Fourati, H ^a   Mnif, E ^b   Ben Mahfoudh, K H ^b   Hachicha, I ^a   Ezzeddine, M ^a   Ayedi F ^b   Mnif, J ^b   Baklouti, S ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Atherosclerosis; Cardiovascular disease; Rheumatoid arthritis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; INFLAMMATORY DISEASE; POPULATION RISK; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTEMIC DISEASE;

ADULT; AGED; ALGORITHMS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84866438042     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2012.04.009     Document Type: Article

References (30)

1. Wallberg-Jonsson S., Ohman M.L., Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997, 24:445-451.
2. Navarro-Cano G., Del Rincon I., Pogosian S., Roldan J.F., Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum 2003, 48:2425-2433.
3. Pasceri V., Yeh E.T. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124-2126.
4. Watson D.J., Rhodes T., Guess H. All-cause mortality and vascular events among patients with rheumatoid arthritis in the UK general practice research database. J Rheumol 2003, 30:1196-1202.
5. Solomon D.H., Curhan G.C., Rimm E.B., Cannuscio C.C., Karlson E.W. Cardiovascular risks in women with and without rheumatoid arthritis. Arthritis Rheum 2004, 50:3344-3349.
6. Weyand C.M., Gornzy J.J., Luizzo G., Kopecky S.L., Holmes D.R. Frye RLl. T cell immunity in acute coronary syndromes. Mayo Clin Proc 2001, 76:1011-1020.
7. Solomon D.H., Karlson E.W., Rimm E.B. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307.
8. Banks M., Flint J., Bacon Pa Kitas G.D. Rheumatoid arthritis is an independent risk factor for ischemic heart disease. Arthritis Rheum 2000, 43(Suppl. 9):385.
9. Park Y.B., Ahn C.W., Choi H.K., Lee S.H., Nam C.M., Lee S.K. Athrosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002, 46:1714-1719.
10. Kumeda Y., Inaba M., Goto H., Nagata M., Henmi Y., Furumitsu Y., et al. Increased thickness of yhe arterial intima-media detected by ultrasonographie in patients with rheumatoid arthritis. Arthritis Rheum 2002, 46(6):1489-1497.
11. Alkaabi J.K., Ho M., Levison R., Pullar T., Belch J.J.F. Rheumatoid arthritis and macrovascular disease. Rheumatology 2003, 42:292-297.
12. Jonsson S.W., Backman C., Johnson O., Karp K., Ludström E., Sundqvist K.G., et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001, 28:2597-2602.
13. Mary J., Moeller E., Davis A., et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006, 144:249-256.
14. Wallberg-Jonsson S., Backman C., Johnson O., et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001, 28:2597-2602.
15. Boers M., Nurmohamed M.T., Doelman C.J., et al. Influence of glucocorticoids and disease activity ontotal and high density lipoprotein cholesterol in patients with rheumatoidarthritis. Ann Rheum Dis 2003, 62:842-845.
16. Georgiadis A.N., Papavasilou E.C., Lourida E.S., et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment-a prospective, controlled study. Arthritis Res Ther 2006, 8:1-7.
17. Cisternas M., Gutierrez M.A., Klaassen J., Acosta A.M., Jacobelli S. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheumatol 2002, 29:1619-1622.
18. Khovidhunki W., Memon R.A., Feingold K.R., Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000, 181:S462-S472.
19. Munro R., Morrison E., McDonald A.G., et al. Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis 1997, 56:374-377.
20. Wan-Hee Y. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles. J Rheumatol 2004, 31:1746-1753.
21. Van Ham V.P., Nielen M.J., Nurmohamed M.T., et al. Lipids and inflammation-serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2006, 16:1-5.
22. Dursunoglu D., Evrengul H., Polat B., et al. Lp (a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 2005, 25:241-245.
23. Flipo R.M. Glucocorticoids and cardiovascular events in rheumatoid arthritis. A population-based cohort study. Arthritis Rheum 2007, 56:820-830.
24. Del Rincon I., O'Leary D.H., Haas R.W. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004, 50:3813-3822.
25. Souverein P.C., Berard A., Van Staa T.P., Cooper C., Egberts A.C.G., Leufkens H.G.M., et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based casecontrol study. Heart 2004, 90:859-865.
26. Choi H.K., Hernan M.A., Seeger J.D., Robins J.M., Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002, 359:1173-1177.
27. Prodanowich S., Fangchao Ma, Taylor J.R., Pezon C., et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005, 52:262-267.
28. Popa C., Netea M.G., Radstake T., et al. Influence of anti-tumour necrosis factors therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis 2005, 64:303-305.
29. McInnes I.B., McCarrey D.W., Sattar N. Do statins offer therapeutic potential in inflammatory arthritis?. Ann Rheum Dis 2004, 63:1535-1537.
30. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20-28.